Lakeridge Health Corporation
8
1
1
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
25%
2 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Effect of Protocolized Magnesium Replacement on Mortality and Atrial Fibrillation in Critically Ill Patients
Role: collaborator
Early Psychosis Intervention - Spreading Evidence-based Treatment
Role: collaborator
Development and Validation of an Online Independent Training Program for TOR-BSST© Dysphagia Screeners
Role: collaborator
Nordic Pole Walking for Individuals With Cancer
Role: collaborator
Evaluate the Value of Telehomecare for Mental Health
Role: collaborator
Toronto Thromboprophylaxis Patient Safety Initiative
Role: collaborator
The Dissemination of Consensus Recommendations on Upper Gastrointestinal Bleeding
Role: collaborator
Ontario ICU Clinical Best Practices Demonstration Project
Role: collaborator
All 8 trials loaded